TrialAlcoholism, clinical and experimental research2012

Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.

Raymond F Anton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.